New cancer drug shows encouraging results in Phase I/II trial
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in ...
Tag: Antibody-Drug Conjugate
A novel therapeutic option for HER2-positive extramammary Paget disease
The research article presents a comprehensive evaluation of the human epidermal growth factor receptor 2 (HER2) status in extramammary Paget ...
